Biology Reference
In-Depth Information
Pietra G, Romagnani C, Falco M, Vitale M, Castriconi R, Pende D, Millo E, Anfossi S, Biassoni
R, Moretta L, Mingari MC (2001) The analysis of the natural killer-like activity of human
cytolytic T lymphocytes revealed HLA-E as a novel target for TCR alpha/beta-mediated rec-
ognition. Eur J Immunol 31:3687-3693
Pietra G, Romagnani C, Mazzarino P, Falco M, Millo E, Moretta A, Moretta L, Mingari MC
(2003) HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+
cytolytic T lymphocytes. Proc Natl Acad Sci U S A 100:10896-10901
Pinto AK, Hill AB (2005) Viral interference with antigen presentation to CD8+ T cells: lessons
from cytomegalovirus. Viral Immunol 18:434-444
Poole E, King CA, Sinclair JH, Alcami A (2006) The UL144 gene product of human cytomega-
lovirus activates NFkappaB via a TRAF6-dependent mechanism. EMBO J 25:4390-4399
Prod'homme V, Griffin C, Aicheler RJ, Wang EC, McSharry BP, Rickards CR, Stanton RJ,
Borysiewicz LK, Lopez-Botet M, Wilkinson GW, Tomasec P (2007) The human cytomegalo-
virus MHC class I homolog UL18 inhibits LIR-1+ but activates LIR-1-NK cells. J Immunol
178:4473-4481
Purcell AW, Gorman JJ, Garcia-Peydro M, Paradela A, Burrows SR, Talbo GH, Laham N, Peh
CA, Reynolds EC, Lopez De Castro JA, McCluskey J (2001) Quantitative and qualitative
influences of tapasin on the class I peptide repertoire. J Immunol 166:1016-1027
Rawlinson WD, Farrell HE, Barrell BG (1996) Analysis of the complete DNA sequence of murine
cytomegalovirus. J Virol 70:8833-8849
Reddehase MJ (2002) Antigens and immunoevasins: opponents in cytomegalovirus immune sur-
veillance. Nat Rev Immunol 2:831-844
Reddehase MJ, Simon CO, Podlech J, Holtappels R (2004) Stalemating a clever opportunist: les-
sons from murine cytomegalovirus. Hum Immunol 65:446-455
Reusch U, Muranyi W, Lucin P, Burgert HG, Hengel H, Koszinowski UH (1999) A cytomegalo-
virus glycoprotein re-routes MHC class I complexes to lysosomes for degradation. EMBO J
18:1081-1091
Reyburn HT, Mandelboim O, Vales-Gomez M, Davis DM, Pazmany L, Strominger JL (1997) The
class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells.
Nature 386:514-517
Rivailler P, Kaur A, Johnson RP, Wang F (2006) Genomic sequence of rhesus cytomegalovirus
180.92: insights into the coding potential of rhesus cytomegalovirus. J Virol 80:4179-4182
Rizvanov AA, van Geelen AG, Morzunov S, Otteson EW, Bohlman C, Pari GS, St Jeor SC (2003)
Generation of a recombinant cytomegalovirus for expression of a hantavirus glycoprotein.
J Virol 77:12203-12210
Robertson MJ, Cochran KJ, Cameron C, Le JM, Tantravahi R, Ritz J (1996) Characterization of
a cell line, NKL, derived from an aggressive human natural killer cell leukemia. Exp Hematol
24:406-415
Rodriguez M, Sabastian P, Clark P, Brown MG (2004) Cmv1-independent antiviral role of NK
cells revealed in murine cytomegalovirus-infected New Zealand White mice. J Immunol
173:6312-6318
Rolle A, Mousavi-Jazi M, Eriksson M, Odeberg J, Soderberg-Naucler C, Cosman D, Karre K,
Cerboni C (2003) Effects of human cytomegalovirus infection on ligands for the activating
NKG2D receptor of NK cells: up-regulation of UL16-binding protein (ULBP)1 and ULBP2 is
counteracted by the viral UL16 protein. J Immunol 171:902-908
Romagnani C, Pietra G, Falco M, Millo E, Mazzarino P, Biassoni R, Moretta A, Moretta L,
Mingari MC (2002) Identification of HLA-E-specific alloreactive T lymphocytes: a cell subset
that undergoes preferential expansion in mixed lymphocyte culture and displays a broad cyto-
lytic activity against allogeneic cells. Proc Natl Acad Sci U S A 99:11328-11333
Romagnani C, Pietra G, Falco M, Mazzarino P, Moretta L, Mingari MC (2004) HLA-E-restricted
recognition of human cytomegalovirus by a subset of cytolytic T lymphocytes. Hum Immunol
65:437-445
Ruger B, Klages S, Walla B, Albrecht J, Fleckenstein B, Tomlinson P, Barrell B (1987) Primary
structure and transcription of the genes coding for the two virion phosphoproteins pp65 and
pp71 of human cytomegalovirus. J Virol 61:446-453
